8-Oct-2024 7:00 AM CST - Business Wire AtriCure to Announce Third Quarter 2024 Financial Results AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, today announced that it will release its third quarter 2024 financial results on Tuesday, October 29, 2024. AtriCure will host an audio webcast at 4:30 p.m. Eastern Time on Tuesday, October 29, 2024, to discuss its third quarter 2024 financial results. Those interested in
Latest ATRC Trades by Congress Members
19-JUL-2024 - Josh Gottheimer, NJ (District 5) purchased between $1,001 and $15,000.
8-Oct-2024 7:00 AM CST - Business Wire AtriCure to Announce Third Quarter 2024 Financial Results AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, today announced that it will release its third quarter 2024 financial results on Tuesday, October 29, 2024. AtriCure will host an audio webcast at 4:30 p.m. Eastern Time on Tuesday, October 29, 2024, to discuss its third quarter 2024 financial results. Those interested in
